|
End-of-day quote
Buenos Aires S.E.
21/08/2026
|
5-day change | 1st Jan Change | ||
| 154.50 ARS | -2.22% |
|
-0.96% | -35.76% |
| Market Cap | 6.58B 4.4M 3.77M 3.52M 3.23M 6.05M 421M 6.13M 41.63M 16.23M 211M 16.51M 16.15M 699M | P/E 2024 |
-3.67x | P/E 2025 | -2.23x |
|---|---|---|---|---|---|
| Enterprise Value | 7.32B 4.89M 4.19M 3.92M 3.59M 6.73M 468M 6.82M 46.3M 18.06M 235M 18.36M 17.96M 777M | EV / Sales 2024 |
0.73x | EV / Sales 2025 | 1.71x |
| Free-Float |
19.84% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -2.22% | ||
| 1 week | -0.96% | ||
| Current month | -3.13% | ||
| 1 month | +0.32% | ||
| 3 months | -4.33% | ||
| 6 months | -25.90% | ||
| Current year | -35.76% |
| 1 week | 153.5 |  | 164 |
| 1 month | 150 | | 165 |
| Current year | 128.5 | | 260 |
| 1 year | 116 | | 357 |
| 3 years | 24 | | 450 |
| 5 years | 9.1 | | 450 |
| 10 years | 4.2 | | 450 |
| Manager | Title | Age | Since |
|---|---|---|---|
Oscar Echeverria
DFI | Director of Finance/CFO | - | 29/07/2010 |
Federico Hoffman
CTO | Chief Tech/Sci/R&D Officer | - | - |
Eduardo Busto
ADM | Chief Administrative Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | 29/07/2010 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.22% | -0.96% | -24.26% | +520.48% | 4.4M | |
| +3.61% | +5.34% | -50.37% | -57.81% | 32.12B | |
| +1.74% | +1.27% | +33.84% | +101.94% | 11.98B | |
| -1.39% | +2.78% | -19.37% | +6.66% | 3.89B | |
| +0.61% | -0.15% | -2.64% | +22.28% | 3.25B | |
| -2.69% | -6.50% | +40.71% | +37.05% | 2.05B | |
| -0.85% | -1.41% | +7.83% | +21.34% | 1.95B | |
| +3.24% | +5.70% | +11.89% | +138.16% | 1.47B | |
| -3.71% | -6.91% | -23.02% | +3.88% | 1.21B | |
| -2.04% | +1.98% | -12.97% | -40.04% | 1.02B | |
| Average | -0.37% | +0.01% | -3.84% | +75.40% | 5.89B | |
| Weighted average by Cap. | +2.11% | +2.97% | -20.73% | -4.25% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 8.27B 5.53M 4.74M 4.43M 4.06M 7.61M 529M 7.71M 52.35M 20.42M 266M 20.76M 20.31M 879M | 6.4B 4.28M 3.66M 3.43M 3.14M 5.89M 409M 5.97M 40.51M 15.8M 206M 16.07M 15.72M 680M |
| Net income | -1.42B -947K -811K -759K -695K -1.3M -90.6M -1.32M -8.97M -3.5M -45.52M -3.56M -3.48M -151M | -4.6B -3.07M -2.63M -2.46M -2.25M -4.23M -294M -4.29M -29.09M -11.34M -148M -11.53M -11.28M -488M |
| Net Debt | 863M 577K 494K 462K 423K 794K 55.18M 805K 5.46M 2.13M 27.72M 2.17M 2.12M 91.68M | 738M 493K 422K 395K 362K 679K 47.16M 688K 4.67M 1.82M 23.69M 1.85M 1.81M 78.36M |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 21/08/26 | ARS 154.50 | -2.22% | 10,893 |
| 20/08/26 | ARS 158.00 | +1.94% | 7,249 |
| 19/08/26 | ARS 155.00 | -1.90% | 6,369 |
| 18/08/26 | ARS 158.00 | +1.28% | 15,265 |
- Stock Market
- Stocks
- ROSE Stock
Select your edition
All financial news and data tailored to specific country editions
